Zacks Company Profile for Medtronic PLC (MDT : NYSE) |
|
|
|
Company Description |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Number of Employees: 90,000 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $106.26 |
Daily Weekly Monthly
 |
20 Day Moving Average: 4,916,811 shares |
Shares Outstanding: 1,341.54 (millions) |
Market Capitalization: $142,551.95 (millions) |
Beta: 0.74 |
52 Week High: $135.89 |
52 Week Low: $98.38 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-3.59% |
5.21% |
12 Week |
2.45% |
7.86% |
Year To Date |
2.72% |
19.73% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Geoffrey S. Martha - Chairman and Chief Executive Officer
KarenL. Parkhill - Executive Vice President and Chief Financial Offic
Bradley E. Lerman - Senior Vice President; General Counsel and Corpora
Carol A. Surface - Senior Vice President and Chief Human Resources Of
Richard Kuntz - Senior Vice President and Chief Medical and Scient
|
|
Peer Information
Medtronic PLC (BJCT)
Medtronic PLC (CADMQ)
Medtronic PLC (APNO)
Medtronic PLC (UPDC)
Medtronic PLC (IMTIQ)
Medtronic PLC (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G5960L103
SIC: 3845
|
|
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 01/01/22
Next Expected EPS Date: 05/26/22
|
|
Share - Related Items
Shares Outstanding: 1,341.54
Most Recent Split Date: 9.00 (2.00:1)
Beta: 0.74
Market Capitalization: $142,551.95 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 2.37% |
Current Fiscal Quarter EPS Consensus Estimate: $1.39 |
Indicated Annual Dividend: $2.52 |
Current Fiscal Year EPS Consensus Estimate: $5.81 |
Payout Ratio: 0.45 |
Number of Estimates in the Fiscal Year Consensus: 13.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: 7.56% |
Last Dividend Paid: 03/24/2022 - $0.63 |
Next EPS Report Date: 05/26/22 |
|
|
|
|